cas 10449-07-7|| where to buy (2-Chlorophenyl)hydrazine

Nom du produit:(2-Chlorophenyl)hydrazine

IUPAC Name:(2-chlorophenyl)hydrazine

Unité d'emballage	Stock disponible	Prix($)
CM344513-1g	1-2 Weeks	ŞǑ
CM344513-5g	3-4 Weeks	ƴƴǑ
CM344513-25g	4-5 Weeks	ǫȯǫ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 10449-07-7 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:10449-07-7; Formule moléculaire:C6H7ClN2; Point de fusion:-; Code SMILES:NNC1=CC=CC=C1Cl; Densité:

: Numéro de catalogue:CM344513; Poids moléculaire:142.59; Point d'ébullition:; N° Mdl:MFCD00982023; Stockage:

: Benzenes; Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

: Setanaxib; Genkyotex SA’s Setanaxib (GKT 831) is a small molecule NOX inhibitor currently in Phase III clinical trials and a potential treatment solution for Primary Biliary Cholangitis (PBC). PBC is a chronic and progressive condition characterized by the inflammation and subsequent destruction of the small bile ducts within the liver. Setanaxib is a novel selective inhibitor of NADPH oxidase (NOX) 1 and 4 isoforms, enabling the downregulation of multiple fibrogenic and inflammatory pathways to prevent progression of liver fibrosis. The mechanism of action of setanaxib involves both anti-fibrotic and anti-inflammatory effects.